Avalo Therapeutics (AVTX) EBIT Margin Growth (3y) (2019 - 2025)
Avalo Therapeutics (AVTX) EBIT Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.25 Mn |
| Dec 31, 2024 | 126,947.00 |
| Sep 30, 2024 | -394,558.00 |
| Dec 31, 2023 | -24,971.00 |
| Sep 30, 2023 | -39,393.00 |
| Jun 30, 2023 | -22,894.00 |
| Mar 31, 2023 | -71,032.00 |
| Dec 31, 2022 | -84,511.00 |
| Sep 30, 2022 | 15,739.00 |
| Jun 30, 2022 | -96,301.00 |
| Mar 31, 2022 | -158,349.00 |
| Dec 31, 2021 | -822,696.00 |
| Sep 30, 2021 | -62,284.00 |
| Jun 30, 2021 | -39,033.00 |
| Mar 31, 2021 | -638,136.00 |
| Dec 31, 2020 | -86,345.00 |
| Sep 30, 2020 | -128,260.00 |
| Jun 30, 2020 | 24,180.00 |
| Mar 31, 2020 | -64,633.00 |
| Dec 31, 2019 | 78,339.00 |